4.5 Article

Variation in tau isoform expression in different brain regions and disease states

Journal

NEUROBIOLOGY OF AGING
Volume 34, Issue 7, Pages -

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2013.01.017

Keywords

Progressive supranuclear palsy; Tauopathies; MAPT

Funding

  1. Intramural Research Program of the National Institute on Aging, National Institutes of Health, Department of Health and Human Services [Z01 AG000932-03]
  2. PSP (Europe) Association
  3. UK Medical Research Council [G0501560, G0400074]
  4. Alzheimer's Society
  5. Alzheimer's Research Trust, Brains for Dementia Research Project
  6. National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust
  7. Newcastle University
  8. MRC [G0700943, G1100540, G1100643, G0400074, G0502157, G0900652, MR/L016451/1, G0501560] Funding Source: UKRI
  9. Alzheimers Research UK [ART-PhD2007-2] Funding Source: researchfish
  10. Brain Research UK [UCC14182] Funding Source: researchfish
  11. Medical Research Council [G0801418B, G0700943, G0501560, G1100540, MR/L016451/1, G0900652, G0502157, G0400074, G1100643] Funding Source: researchfish
  12. Parkinson's UK [K-1212] Funding Source: researchfish

Ask authors/readers for more resources

Progressive supranuclear palsy (PSP) is the most common atypical parkinsonian disorder. Abnormal tau inclusions, in selected regions of the brain, are a hallmark of the disease and the H1 haplotype of MAPT, the gene encoding tau, is the major risk factor in PSP. A 3-repeat and 4-repeat (4R) tau isoform ratio imbalance has been strongly implicated as a cause of disease. Thus, understanding tau isoform regional expression in disease and pathology-free states is crucial to elucidating the mechanisms involved in PSP and other tauopathies. We used a tau isoform-specific fluorescent assay to investigate relative 4R-tau expression in 6 different brain regions in PSP cases and healthy control samples. We identified a marked difference in 4R-tau relative expression, across brain regions and between MAPT haplotypes. Highest 4R-tau expression levels were identified in the globus pallidus compared with pons, cerebellum, and frontal cortex. 4R-tau expression levels were related to the MAPT H1 and H1c haplotypes. Similar regional variation was seen in PSP case and in control samples. (C) 2013 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available